TSX:AEZS - Post Discussion
Post by
ITSUP2ME on Mar 16, 2021 8:11am
Mirror image....
Vaxart Inc is a clinical-stage biotechnology company. It focuses on the development of oral recombinant vaccines to protect against a wide range of infectious diseases. The products under its tablet pipeline consist of the treatment of Coronavirus, Norovirus, Seasonal Influenza, RSV(respiratory syncytial virus), and HPV(Human papillomavirus) Therapeutic. It operates in a single segment, which is the discovery and development of oral recombinant protein vaccines. Geographically all the business a
$6.880.14 | 2.08%Bid: 6.86 x 100Ask: 6.93 x 200Volume: 3,472,355
After Hours: $6.92 0.04 | 0.58%March 15, 2021 7:59 PMEDTVolume: 32,463
:)
Be the first to comment on this post